MeiraGTx’s investigational gene therapy AAV-AIPL1 has improved the sight of 11 c...
Teva Pharmaceuticals and Alvotech have announced the US launch of Selarsdi (uste...
Mirum Pharmaceuticals’ Ctexli (chenodiol) has gained US Food and Drug Administra...
Sionna Therapeutics recently secured an initial public offering (IPO) of $191m o...
The FDA has accepted Bristol Myers Squibb’s (BMS) supplemental biologics licence...
Pfizer has signed a deal with Summit Therapeutics to assess the efficacy of Summ...
Celltrion has secured marketing authorisation from the EC for Avtozma, a biosimi...
PHARMAP 2025 takes place on 14-15 April 2025 in Berlin, Germany.
With Novo Nordisk’s blockbuster drugs Wegovy and Ozempic back in stock, copycat ...
The field of central nervous system (CNS) drug development is awash with activit...
BMS' Breyanzi and Amgen’s Blincyto will now be available to patients in England ...
Incyte and Genesis have entered a strategic partnership for the research, discov...
Bluebird has faced financial pressures over the last few years, leading to sever...
Pfizer said resources will be directed to its other haemophilia gene therapy Hym...
UroGen Pharma has broadened its oncology pipeline by acquiring IconOVir Bio’s as...
